Development of a Novel Method for the Identification and Characterization of Intercellular Communication in the Cancer Niche

开发一种用于识别和表征癌症生态位中细胞间通讯的新方法

基本信息

  • 批准号:
    10426930
  • 负责人:
  • 金额:
    $ 7.75万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-09-01 至 2024-08-31
  • 项目状态:
    已结题

项目摘要

ABSTRACT Intercellular interactions and communication between cancer cells the cells that comprise their niches are critical for many aspects of cancer development, progression, metastasis, and therapy resistance. These interactions are often dynamic, transient and complex. Moreover, intercellular communication occurs directly by contact dependent cell-cell interactions and indirectly by the secretion of soluble factors into the local microenvironment. Current limitations to proximity dependent labeling strategies designed to identify and characterize direct and indirect cellular interaction partners in vivo include reagents that are toxic and/or limit the isolation and subsequent characterization of interacting cells, non-specific or large radius labeling (i.e. direct vs. indirect contacts), or a requirement to pre-engineer both interacting cells which obviates the possibility of identifying novel cellular interaction partners. Thus, a more ideal in vivo proximity dependent labeling system would concurrently, but differentially, label both direct and indirect cellular contacts at multiple timepoints using technology that is compatible with an array of downstream analyses ranging from microscopy to single cell analyses. In this proposal we will address this shortcoming in current technologies for comprehensively identifying and characterizing direct and indirect intercellular interactions in vivo. We will build upon the literature and our preliminary work to develop a novel approach in which an engineered cancer cell, or other cell of interest, concurrently, differentially and temporally fluorescently labels both direct and indirect cellular contacts within the cancer niche (Aims 1 and 2). Importantly, labeled cells will be suitable for an array of downstream analyses such as microscopy, flow cytometry, and cell sorting followed by bulk or single cell analyses. Accordingly, as proof-of-concept we will then combine this niche labeling technology with single-cell RNA-seq to begin to define cellular contacts during early stages of central nervous system leukemia metastasis and niche development (Aim 3).
摘要 癌细胞之间的细胞间相互作用和通信构成它们的小生境的细胞是 对于癌症发展、进展、转移和治疗抗性的许多方面至关重要。这些 互动往往是动态的、短暂的和复杂的。此外,细胞间通讯直接发生在 通过接触依赖性细胞-细胞相互作用和间接通过可溶性因子分泌到局部 微环境设计用于识别和鉴定的邻近依赖性标记策略的当前局限性 表征体内直接和间接细胞相互作用配偶体的试剂包括毒性和/或限制性的试剂 相互作用细胞的分离和随后的表征,非特异性或大半径标记(即, 直接与间接接触),或者需要预先设计两个相互作用的细胞,这避免了 识别新的细胞相互作用伙伴的可能性。因此,更理想的体内邻近依赖 标记系统将同时但不同地标记多个细胞的直接和间接细胞接触。 使用与一系列下游分析兼容的技术, 单细胞分析。在本提案中,我们将解决当前技术中的这一缺点, 全面鉴定和表征体内直接和间接的细胞间相互作用。我们将建立 基于文献和我们开发新方法的初步工作, 或其它感兴趣的细胞同时、有差别地和暂时地直接和间接地荧光标记 癌症小生境内的细胞接触(目的1和2)。重要的是,标记的细胞将适合于阵列 下游分析,如显微镜,流式细胞术和细胞分选,然后进行批量或单细胞 分析。因此,作为概念验证,我们将联合收割机将这种小生境标记技术与单细胞 RNA-seq开始定义中枢神经系统白血病早期阶段的细胞接触 转移和生态位发育(Aim 3)。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

PETER M GORDON其他文献

PETER M GORDON的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('PETER M GORDON', 18)}}的其他基金

A Novel VpreB1 Anti-body Drug Conjugate for the Treatment of B-Lineage Acute Lymphoblastic Leukemia/Lymphoma
一种用于治疗 B 系急性淋巴细胞白血病/淋巴瘤的新型 VpreB1 抗体药物偶联物
  • 批准号:
    10651082
  • 财政年份:
    2023
  • 资助金额:
    $ 7.75万
  • 项目类别:
Overcoming Leukemia Chemoresistance in the Central Nervous System
克服中枢神经系统的白血病化疗耐药性
  • 批准号:
    10591475
  • 财政年份:
    2020
  • 资助金额:
    $ 7.75万
  • 项目类别:
Overcoming Leukemia Chemoresistance in the Central Nervous System
克服中枢神经系统的白血病化疗耐药性
  • 批准号:
    10357911
  • 财政年份:
    2020
  • 资助金额:
    $ 7.75万
  • 项目类别:
Autophagy and Apoptosis in the Response of c-KIT Cancers to Targeted Therapy
c-KIT 癌症对靶向治疗的反应中的自噬和凋亡
  • 批准号:
    8913061
  • 财政年份:
    2011
  • 资助金额:
    $ 7.75万
  • 项目类别:
Autophagy and apoptosis in the response of c-KIT cancers to targeted therapy
c-KIT 癌症对靶向治疗反应中的自噬和凋亡
  • 批准号:
    8537381
  • 财政年份:
    2011
  • 资助金额:
    $ 7.75万
  • 项目类别:
Autophagy and apoptosis in the response of c-KIT cancers to targeted therapy
c-KIT 癌症对靶向治疗反应中的自噬和凋亡
  • 批准号:
    8334457
  • 财政年份:
    2011
  • 资助金额:
    $ 7.75万
  • 项目类别:
Autophagy and Apoptosis in the Response of c-KIT Cancers to Targeted Therapy
c-KIT 癌症对靶向治疗的反应中的自噬和凋亡
  • 批准号:
    8837386
  • 财政年份:
    2011
  • 资助金额:
    $ 7.75万
  • 项目类别:
Autophagy and Apoptosis in the Response of c-KIT Cancers to Targeted Therapy
c-KIT 癌症对靶向治疗的反应中的自噬和凋亡
  • 批准号:
    8712410
  • 财政年份:
    2011
  • 资助金额:
    $ 7.75万
  • 项目类别:
Autophagy and apoptosis in the response of c-KIT cancers to targeted therapy
c-KIT 癌症对靶向治疗反应中的自噬和凋亡
  • 批准号:
    8190091
  • 财政年份:
    2011
  • 资助金额:
    $ 7.75万
  • 项目类别:

相似海外基金

Nonlocal Variational Problems from Physical and Biological Models
物理和生物模型的非局部变分问题
  • 批准号:
    2306962
  • 财政年份:
    2023
  • 资助金额:
    $ 7.75万
  • 项目类别:
    Standard Grant
Point-of-care optical spectroscopy platform and novel ratio-metric algorithms for rapid and systematic functional characterization of biological models in vivo
即时光学光谱平台和新颖的比率度量算法,可快速、系统地表征体内生物模型的功能
  • 批准号:
    10655174
  • 财政年份:
    2023
  • 资助金额:
    $ 7.75万
  • 项目类别:
Multi-scale stochastic systems motivated by biological models
由生物模型驱动的多尺度随机系统
  • 批准号:
    RGPIN-2015-06573
  • 财政年份:
    2022
  • 资助金额:
    $ 7.75万
  • 项目类别:
    Discovery Grants Program - Individual
Micro-electrofluidic platforms for monitoring 3D human biological models
用于监测 3D 人体生物模型的微电流体平台
  • 批准号:
    DP220102872
  • 财政年份:
    2022
  • 资助金额:
    $ 7.75万
  • 项目类别:
    Discovery Projects
Multi-scale stochastic systems motivated by biological models
由生物模型驱动的多尺度随机系统
  • 批准号:
    RGPIN-2015-06573
  • 财政年份:
    2021
  • 资助金额:
    $ 7.75万
  • 项目类别:
    Discovery Grants Program - Individual
Multi-scale stochastic systems motivated by biological models
由生物模型驱动的多尺度随机系统
  • 批准号:
    RGPIN-2015-06573
  • 财政年份:
    2020
  • 资助金额:
    $ 7.75万
  • 项目类别:
    Discovery Grants Program - Individual
Harnessing machine learning and cloud computing to test biological models of the role of white matter in human learning
利用机器学习和云计算来测试白质在人类学习中的作用的生物模型
  • 批准号:
    2004877
  • 财政年份:
    2020
  • 资助金额:
    $ 7.75万
  • 项目类别:
    Fellowship Award
A Portable low-cost, Point of Investigation CapCell Scope to Image and Quantify the Major Axes of Metabolism and the Associated Vasculature in In vitro and In vivo Biological Models
便携式低成本调查点 CapCell 示波器,用于对体外和体内生物模型中的主要代谢轴和相关脉管系统进行成像和量化
  • 批准号:
    9899988
  • 财政年份:
    2019
  • 资助金额:
    $ 7.75万
  • 项目类别:
Multi-scale stochastic systems motivated by biological models
由生物模型驱动的多尺度随机系统
  • 批准号:
    RGPIN-2015-06573
  • 财政年份:
    2019
  • 资助金额:
    $ 7.75万
  • 项目类别:
    Discovery Grants Program - Individual
A Portable low-cost, Point of Investigation CapCell Scope to Image and Quantify the Major Axes of Metabolism and the Associated Vasculature in In vitro and In vivo Biological Models
便携式低成本调查点 CapCell 示波器,用于对体外和体内生物模型中的主要代谢轴和相关脉管系统进行成像和量化
  • 批准号:
    9753458
  • 财政年份:
    2019
  • 资助金额:
    $ 7.75万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了